PS
Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1076
Hancock Whitney
HWC
$5.33B
|
BM
Brad Milsaps
| $62.90 | $55 |
13%
downside
| Overweight |
17 Jan ‘24
1 year ago |
|
|
RENT
1077
Rent the Runway
RENT
$26.1M
|
EY
Edward Yruma
| $6.38 | $15 |
135%
upside
| Neutral |
17 Jan ‘24
1 year ago |
|
1078
Axsome Therapeutics
AXSM
$6.45B
|
DA
David Amsellem
| $129.29 | $113 |
13%
downside
| Overweight |
16 Jan ‘24
1 year ago |
|
1079
Hormel Foods
HRL
$14B
|
ML
Michael Lavery
| $25.50 | $33 |
29%
upside
| Neutral |
12 Jan ‘24
1 year ago |
|
1080
Nicolet Bankshares
NIC
$2.05B
|
NR
Nathan Rice
| $137.68 | $84 |
39%
downside
| Neutral |
10 Jan ‘24
1 year ago |
|
|
BBT
1081
Beacon Financial Corporation
BBT
$2.26B
|
MF
Mark Fitzgibbon
| $26.83 | $24 |
11%
downside
| Neutral |
10 Jan ‘24
1 year ago |
|
1082
Semrush
SEMR
$1.16B
|
BB
Brent Bracelin
| $7.78 | $14 |
80%
upside
| Neutral |
9 Jan ‘24
1 year ago |
|
1083
Southern First Bancshares
SFST
$369M
|
COW
Casey Orr Whitman
| $45.08 | $44 |
2%
downside
| Overweight |
3 Jan ‘24
1 year ago |
|
1084
Xponential Fitness
XPOF
$305M
|
PK
Peter Keith
| $8.69 | $13 |
50%
upside
| Neutral |
3 Jan ‘24
1 year ago |
|
|
KLRS
1085
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.8M
|
CR
Christopher Raymond
| $4.64 | $34.50 |
644%
upside
| Neutral |
22 Dec ‘23
1 year ago |
|
1086
SEI Investments
SEIC
$10.8B
|
SM
Sumeet Mody
| $87.43 | $66 |
25%
downside
| Neutral |
20 Dec ‘23
1 year ago |
|
1087
Webster Financial
WBS
$10.3B
|
MB
Matthew Breese
| $62.08 | $60 |
3%
downside
| Overweight |
15 Dec ‘23
1 year ago |
|
1088
Allbirds
BIRD
$49.4M
|
EY
Edward Yruma
| $6.07 | $32 |
427%
upside
| Neutral |
14 Dec ‘23
1 year ago |
|
|
OKUR
1089
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$35.6M
|
YR
Yasmeen Rahimi
| $2.63 | $40 |
1,421%
upside
| Neutral |
14 Dec ‘23
1 year ago |
|
1090
Truist Financial
TFC
$59.3B
|
SS
Stephen Scouten
| $46.01 | $34 |
26%
downside
| Neutral |
8 Dec ‘23
1 year ago |
|
1091
Kingstone Companies
KINS
$189M
|
PN
Paul Newsome
| $13.36 | $1.75 |
87%
downside
| Underweight |
20 Nov ‘23
1 year ago |
|
|
TVRD
1092
Tvardi Therapeutics, Inc. Common Stock
TVRD
$278M
|
DA
David Amsellem
| $29.66 | $36 |
21%
upside
| Neutral |
14 Nov ‘23
1 year ago |
|
1093
Helmerich & Payne
HP
$1.99B
|
LL
Luke Lemoine
| $20.04 | $47 |
135%
upside
| Overweight |
13 Nov ‘23
1 year ago |
|
1094
Conifer Holdings
CNFR
$9.26M
|
PN
Paul Newsome
| $0.7575 | $0.6100 |
19%
downside
| Underweight |
13 Nov ‘23
1 year ago |
|
|
IMDX
1095
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71.3M
|
DW
David Westenberg
| $2.49 | $3 |
20%
upside
| Neutral |
13 Nov ‘23
1 year ago |
|
1096
Humacyte
HUMA
$223M
|
MO
Matt O'Brien
| $1.41 | $3 |
113%
upside
| Neutral |
10 Nov ‘23
1 year ago |
|
1097
Wolverine World Wide
WWW
$2.58B
|
AZ
Abbie Zvejnieks
| $31.74 | $11 |
65%
downside
| Neutral |
10 Nov ‘23
1 year ago |
|
1098
Affirm
AFRM
$28B
|
KB
Kevin Barker
| $85.88 | $12 |
86%
downside
| Underweight |
9 Nov ‘23
1 year ago |
|
1099
Under Armour
UAA
$2.19B
|
AZ
Abbie Zvejnieks
| $5.10 | $8.50 |
67%
upside
| Neutral |
9 Nov ‘23
1 year ago |
|
1100
Toast
TOST
$23.8B
|
BB
Brent Bracelin
| $40.75 | $17 |
58%
downside
| Neutral |
8 Nov ‘23
1 year ago |
|